Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 patients with severe disease were significantly less likely to require mechanical ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced encouraging initial data from an ongoing Phase 1/2/3 clinical trial of the Regeneron antibody cocktail, casirivimab and imdevimab, in ...
Among hospitalized COVID-19 patients, the use of high-flow oxygen through a nasal cannula reduced the need for invasive mechanical ventilation and sped up recovery compared to conventional oxygen ...
In hospitalized veterans with COVID-19, obstructive sleep apnea (OSA) was associated with greater use of non-invasive ventilation (NIV), but booster vaccination reduced this risk, a retrospective ...
Please provide your email address to receive an email when new articles are posted on . Higher dose vs. low dose corticosteroids raises the risk for mortality by 60% in this patient population. Those ...
LA JOLLA, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica” or the “Company), a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced encouraging initial data from an ongoing Phase 1/2/3 clinical trial of the Regeneron antibody cocktail, casirivimab and imdevimab, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback